» Articles » PMID: 19934041

Synergy Between Bacterial Infection and Genetic Predisposition in Intestinal Dysplasia

Overview
Specialty Science
Date 2009 Nov 26
PMID 19934041
Citations 131
Authors
Affiliations
Soon will be listed here.
Abstract

Accumulating evidence suggests that hyperproliferating intestinal stem cells (SCs) and progenitors drive cancer initiation, maintenance, and metastasis. In addition, chronic inflammation and infection have been increasingly recognized for their roles in cancer. Nevertheless, the mechanisms by which bacterial infections can initiate SC-mediated tumorigenesis remain elusive. Using a Drosophila model of gut pathogenesis, we show that intestinal infection with Pseudomonas aeruginosa, a human opportunistic bacterial pathogen, activates the c-Jun N-terminal kinase (JNK) pathway, a hallmark of the host stress response. This, in turn, causes apoptosis of enterocytes, the largest class of differentiated intestinal cells, and promotes a dramatic proliferation of SCs and progenitors that serves as a homeostatic compensatory mechanism to replenish the apoptotic enterocytes. However, we find that this homeostatic mechanism can lead to massive over-proliferation of intestinal cells when infection occurs in animals with a latent oncogenic form of the Ras1 oncogene. The affected intestines develop excess layers of cells with altered apicobasal polarity reminiscent of dysplasia, suggesting that infection can directly synergize with the genetic background in predisposed individuals to initiate SC-mediated tumorigenesis. Our results provide a framework for the study of intestinal bacterial infections and their effects on undifferentiated and mature enteric epithelial cells in the initial stages of intestinal cancer. Assessment of progenitor cell responses to pathogenic intestinal bacteria could provide a measure of predisposition for apoptotic enterocyte-assisted intestinal dysplasias in humans.

Citing Articles

Aberrant enterocyte progenitor clustering as an early life biomarker of aging.

Neophytou C, Teloni S, Koumouri M, Stefanutti M, Gianni P, Yilmaz V iScience. 2025; 28(3):111967.

PMID: 40060901 PMC: 11889619. DOI: 10.1016/j.isci.2025.111967.


Alterations in ether phospholipids metabolism activate the conserved UPR-Xbp1- PDIA3/ERp60 signaling to maintain intestinal homeostasis.

Makdissi S, Loudhaief R, George S, Weller T, Salim M, Malick A iScience. 2025; 28(3):111946.

PMID: 40034858 PMC: 11872617. DOI: 10.1016/j.isci.2025.111946.


Nora virus proliferates in dividing intestinal stem cells and sensitizes flies to intestinal infection and oxidative stress.

Franchet A, Haller S, Yamba M, Barbier V, Thomaz-Vieira A, Leclerc V bioRxiv. 2025; .

PMID: 39975242 PMC: 11838516. DOI: 10.1101/2025.01.30.635658.


Ingestion of Bacillus cereus spores dampens the immune response to favor bacterial persistence.

Hachfi S, Brun-Barale A, Fichant A, Munro P, Nawrot-Esposito M, Michel G Nat Commun. 2024; 15(1):7733.

PMID: 39231950 PMC: 11375157. DOI: 10.1038/s41467-024-51689-9.


Nanoparticle Uptake in the Aging and Oncogenic Midgut Measured with Surface-Enhanced Raman Spectroscopy.

Christou M, Fidelix A, Apidianakis Y, Andreou C Cells. 2024; 13(16.

PMID: 39195234 PMC: 11353203. DOI: 10.3390/cells13161344.


References
1.
Kanda H, Miura M . Regulatory roles of JNK in programmed cell death. J Biochem. 2004; 136(1):1-6. DOI: 10.1093/jb/mvh098. View

2.
Quante M, Wang T . Inflammation and stem cells in gastrointestinal carcinogenesis. Physiology (Bethesda). 2008; 23:350-9. PMC: 2705777. DOI: 10.1152/physiol.00031.2008. View

3.
Ricci-Vitiani L, Lombardi D, Pilozzi E, Biffoni M, Todaro M, Peschle C . Identification and expansion of human colon-cancer-initiating cells. Nature. 2006; 445(7123):111-5. DOI: 10.1038/nature05384. View

4.
Ohlstein B, Spradling A . Multipotent Drosophila intestinal stem cells specify daughter cell fates by differential notch signaling. Science. 2007; 315(5814):988-92. DOI: 10.1126/science.1136606. View

5.
Boman B, Huang E . Human colon cancer stem cells: a new paradigm in gastrointestinal oncology. J Clin Oncol. 2008; 26(17):2828-38. DOI: 10.1200/JCO.2008.17.6941. View